Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in Japan

PURPOSE: To investigate the clinical predictive factors for the efficacy of everolimus (EVE) for advanced/metastatic breast cancer (AMBC). METHODS: Routine practice data of consecutive patients with AMBC who received EVE at 5 institutions in western Japan were retrospectively analyzed in this cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikawa, Yuichiro, Kotake, Takeshi, Kajiwara, Yukiko, Hashimoto, Kazuki, Yamashiro, Hiroyasu, Ohtani, Shoichiro, Takao, Shintaro, Toi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343452/
https://www.ncbi.nlm.nih.gov/pubmed/30733627
http://dx.doi.org/10.1177/1178223418825135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343452/
https://www.ncbi.nlm.nih.gov/pubmed/30733627
http://dx.doi.org/10.1177/1178223418825135

Ejemplares similares